05/22/2026
ICYMI: The University of South Carolina has entered into a licensing agreement with 20/20 BioLabs Inc. to commercialize a patented prostate cancer risk assessment algorithm developed by USC researcher Dr. James Hébert. The partnership demonstrates how collaboration between USC and industry helps drive innovation — turning groundbreaking research into technologies that can improve lives and advance the future of health care in South Carolina and beyond.
Read More: https://www.sc.edu/uofsc/posts/2026/05/05-uofsc-2020biolabs-cancer-screening-licensing.php
Arnold School of Public Health at South Carolina
USC Research
S.C. Department of Commerce
SCbio
The University of South Carolina has agreed to license an algorithm developed by a renowned cancer and nutritional epidemiologist to 20/20 BioLabs, a health sciences company that offers home cancer screening tests.